eBook:

Increasing Diversity in Clinical Trials: A Comprehensive Guide for Pharma Companies

Drive health equity by increasing diversity in your clinical trials.

The lack of diversity in clinical trials is one of the biggest obstacles to achieving true health equity. Despite making up a significant portion of the U.S. population, communities of color have historically been underrepresented in clinical research.

This lack of representation means treatments are not adequately tested on diverse populations, leading to skewed data, unfavorable health outcomes, rising healthcare costs, and a perpetuation of existing health inequalities.

The FDA has taken note, issuing new draft guidance that recommends pharmaceutical companies submit race and ethnicity diversity action plans for clinical trials—or risk delays. Building a robust strategy to improve diversity is now a necessity, as well as an ethical imperative.

This eBook is perfect if you want to learn:

The profound impacts of diversity in clinical trials on health equity
How to build affective trust with communities of color to increase participation
Strategies for developing a robust FDA-compliant diversity action plan
The role of innovative technology in enabling diversity outreach

Fill out the form to download the guide.

What's Inside:

Our guide explores strategies to enhance diversity and inclusivity in clinical research.

You'll learn:

The historical context and root causes behind the lack of diversity in clinical trials
Actionable steps to cultivate affective trust with communities of color
Best practices for developing an FDA-compliant diversity action plan
How to leverage technology and analytics for targeted diversity outreach

Download this in-depth guide to gain a comprehensive understanding of clinical trial diversity challenges and solutions to drive health equity.

Download the eBook

Chapter 1: Perspectives on Clinical Trial Diversity

Examine the current state of diversity in clinical trials, why inclusivity is so vital, and the stark consequences of underrepresented populations.

Chapter 2: The Impacts of Clinical Trial Diversity on Health Equity

A revealing look at the financial impacts and human costs of non-diverse clinical trial research.

Chapter 3: Overcoming Clinical Research Challenges: Why Affective Trust Matters

Understand the deep-rooted mistrust of the medical system by communities of color due to a long history of exploitation. Learn practical strategies for building affective trust to overcome recruitment challenges.

Chapter 4: Building a Strong Diversity Plan

We break down the latest FDA guidance, including recommendations on data collection, reporting, and more. You'll also learn how technology can support clinical trial diversity goals.

Chapter 5: Dispelling 5 Myths About Recent FDA Guidance

Our very own Chief Medical Lead, Camille Pope, PharmD, RPh clears up common misconceptions about the FDA’s recent Diversity Action Plan guidance to help reinforce your compliance efforts.

Chapter 6: FDA Diversity in Clinical Trials: A 5-Step Template for Effective Action

Leverage this step-by-step template for developing a Diversity Action Plan that considers the FDA’s latest guidance.

Increasing Diversity in Clinical Trials: A Comprehensive Guide for Pharma Companies

Drive health equity by increasing diversity in your clinical trials.

What's Inside:

Contents